This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lifemax Laboratories, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Tzu-Ying Wu: Innovator in Pharmaceutical Formulations
Introduction: Tzu-Ying Wu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended release medications. His work focuses on improving the efficacy and delivery of important therapeutic agents.
Latest Patents: Tzu-Ying Wu holds a patent for an "Extended release suspension formulation of lurasidone." This patent relates to depot formulations of lurasidone and outlines methods for creating these formulations. The depot formulations include a suspending agent and are designed to be highly syringeable, enhancing their usability in clinical settings.
Career Highlights: Wu is currently associated with Lifemax Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in formulation science has positioned him as a valuable asset in the development of new therapeutic solutions.
Collaborations: Tzu-Ying Wu has collaborated with talented colleagues such as Wei-Hsiang Wang and Chia-Yu Kuo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion: Tzu-Ying Wu's contributions to pharmaceutical formulations, particularly through his patent on lurasidone, highlight his role as an important inventor in the field. His work continues to impact the development of effective medications, showcasing the significance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile